Global Peptide Therapeutics Competitive Landscape Professional Research Report 2025
Research Summary
Peptide therapeutics are a class of pharmaceutical drugs composed of short chains of amino acids, known as peptides, that are designed to target specific biological molecules or pathways to treat various medical conditions and diseases. These therapeutic peptides can mimic the activity of natural peptides or proteins in the body, regulate or inhibit certain biochemical processes, and interact with specific receptors or enzymes. They are highly precise and often have fewer side effects compared to traditional small-molecule drugs. Peptide therapeutics have been developed for a wide range of medical applications, including treating cancer, diabetes, autoimmune disorders, infectious diseases, and more. Due to their specificity and effectiveness, peptide-based drugs have gained significant attention in the pharmaceutical industry, and ongoing research and development continue to expand the use of peptide therapeutics for various healthcare needs.
According to DIResearch's in-depth investigation and research, the global Peptide Therapeutics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Peptide Therapeutics include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, Johnson & Johnson etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peptide Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Peptide Therapeutics Include:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
Johnson & Johnson
Peptide Therapeutics Product Segment Include:
Injection Peptide Therapeutics
Oral Peptide Therapeutics
Others
Peptide Therapeutics Product Application Include:
Cancer
Metabolic Disorders
Central Nervous System
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Peptide Therapeutics Industry PESTEL Analysis
Chapter 3: Global Peptide Therapeutics Industry Porter’s Five Forces Analysis
Chapter 4: Global Peptide Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Peptide Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Peptide Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Peptide Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Peptide Therapeutics Product by Type
- 1.2.1 Injection Peptide Therapeutics
- 1.2.2 Oral Peptide Therapeutics
- 1.2.3 Others
- 1.3 Peptide Therapeutics Product by Application
- 1.3.1 Cancer
- 1.3.2 Metabolic Disorders
- 1.3.3 Central Nervous System
- 1.3.4 Others
- 1.4 Global Peptide Therapeutics Market Size Analysis (2020-2032)
- 1.5 Peptide Therapeutics Market Development Status and Trends
- 1.5.1 Peptide Therapeutics Industry Development Status Analysis
- 1.5.2 Peptide Therapeutics Industry Development Trends Analysis
- 2 Peptide Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Peptide Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Peptide Therapeutics Market Analysis by Regions
- 4.1 Peptide Therapeutics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Peptide Therapeutics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Peptide Therapeutics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Peptide Therapeutics Revenue Forecast by Region (2026-2032)
- 5 Global Peptide Therapeutics Market Size by Type and Application
- 5.1 Global Peptide Therapeutics Market Size by Type (2020-2032)
- 5.2 Global Peptide Therapeutics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Peptide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Peptide Therapeutics Market Size by Type
- 6.4 North America Peptide Therapeutics Market Size by Application
- 6.5 North America Peptide Therapeutics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Peptide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Peptide Therapeutics Market Size by Type
- 7.4 Europe Peptide Therapeutics Market Size by Application
- 7.5 Europe Peptide Therapeutics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Peptide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Peptide Therapeutics Market Size by Type
- 8.4 China Peptide Therapeutics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Peptide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Peptide Therapeutics Market Size by Type
- 9.4 APAC (excl. China) Peptide Therapeutics Market Size by Application
- 9.5 APAC (excl. China) Peptide Therapeutics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Peptide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Peptide Therapeutics Market Size by Type
- 10.4 Latin America Peptide Therapeutics Market Size by Application
- 10.5 Latin America Peptide Therapeutics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Peptide Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Peptide Therapeutics Market Size by Type
- 11.4 Middle East & Africa Peptide Therapeutics Market Size by Application
- 11.5 Middle East & Africa Peptide Therapeutics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Peptide Therapeutics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Peptide Therapeutics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Peptide Therapeutics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Sanofi
- 13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Sanofi Peptide Therapeutics Product Portfolio
- 13.1.3 Sanofi Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Teva
- 13.2.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Teva Peptide Therapeutics Product Portfolio
- 13.2.3 Teva Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Novo Nordisk
- 13.3.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Novo Nordisk Peptide Therapeutics Product Portfolio
- 13.3.3 Novo Nordisk Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Takeda
- 13.4.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Takeda Peptide Therapeutics Product Portfolio
- 13.4.3 Takeda Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Eli Lilly
- 13.5.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Eli Lilly Peptide Therapeutics Product Portfolio
- 13.5.3 Eli Lilly Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 AstraZeneca
- 13.6.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 AstraZeneca Peptide Therapeutics Product Portfolio
- 13.6.3 AstraZeneca Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Novartis
- 13.7.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Novartis Peptide Therapeutics Product Portfolio
- 13.7.3 Novartis Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 AbbVie
- 13.8.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 AbbVie Peptide Therapeutics Product Portfolio
- 13.8.3 AbbVie Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Ipsen
- 13.9.1 Ipsen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Ipsen Peptide Therapeutics Product Portfolio
- 13.9.3 Ipsen Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Ferring
- 13.10.1 Ferring Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Ferring Peptide Therapeutics Product Portfolio
- 13.10.3 Ferring Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Merck
- 13.11.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Merck Peptide Therapeutics Product Portfolio
- 13.11.3 Merck Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 The Medicines
- 13.12.1 The Medicines Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 The Medicines Peptide Therapeutics Product Portfolio
- 13.12.3 The Medicines Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Johnson & Johnson
- 13.13.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Johnson & Johnson Peptide Therapeutics Product Portfolio
- 13.13.3 Johnson & Johnson Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Peptide Therapeutics Industry Chain Analysis
- 14.2 Peptide Therapeutics Industry Raw Material and Suppliers Analysis
- 14.2.1 Peptide Therapeutics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Peptide Therapeutics Typical Downstream Customers
- 14.4 Peptide Therapeutics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook